Medicines manufacturing in the Czech Republic
What they said about us
„Generic and biosimilar drugs reduce health care costs and thanks to that, treatment is accessible to more patients who need it and can access it in an earlier stage of a disease.”
„We view generic drugs and biosimilars as very important for the securing of health care sustainability and the budget stability of health insurance companies. Generics and biosimilars allow us to increase the number of treated patients and provide better treatment accessibility.”
„Sadly, the number of chronically ill patients is increasing. However, thanks to our activity in the area of generics and biosimilars, treatment is accessible to a higher number of patients, and we manage to stabilize the expenses.”